Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
HAIFA, Israel - In a groundbreaking partnership, leading biotechnology company Pluri Inc. has joined forces with Wilk Technologies Ltd. to develop a novel medical food solution for the elderly. Pluri, known for its innovative cell transformation technologies, will combine its cutting-edge 3D cell-expansion technology with Wilk Technologies’ expertise in developing cultured human breast and animal milk products. Together, they aim to create a unique and commercially viable medical food product derived from the components of breast milk.
The elderly population faces unique nutritional challenges that require tailored solutions to support their overall wellbeing. Malnourishment, sarcopenia (muscle loss), and decreased immune function are some of the common issues faced by older adults. Recognizing this, Pluri and Wilk Technologies have come together to leverage the powerful and well-documented health benefits of breast milk components to address these specific needs.
Breast milk is nature’s perfect food, containing a complex blend of nutrients, growth factors, bioactive compounds, and immune-boosting molecules. It is known to support optimal growth and development in infants, offering protection against infections and promoting a healthy gut microbiome. By harnessing the components of breast milk, Pluri and Wilk Technologies aim to develop a medical food that can provide similar benefits to the elderly population.
Pluri’s innovative 3D cell-expansion technology allows for the large-scale cultivation of cells, paving the way for efficient production of breast milk components. This cutting-edge approach ensures that the final product retains the integrity and functionality of the original breast milk components, offering a safe and reliable source of nutrition for the elderly.
The collaboration between Pluri and Wilk Technologies brings together a wealth of expertise. Wilk Technologies has a proven track record in developing cell-cultured human and animal milk products, ensuring that the derived food product meets the highest standards of quality and safety.
With the global population of elderly individuals projected to increase significantly in the coming years, addressing their unique nutritional needs is crucial. The partnership between Pluri and Wilk Technologies not only holds promise for developing a groundbreaking medical food solution for the elderly but also demonstrates the potential of cell-based technologies to revolutionize the food industry.
By leveraging the components of breast milk, the medical food product being developed has the potential to support healthy aging, improve nutritional status, and enhance overall wellbeing among the elderly. The inclusion of breast milk components will be based on rigorous scientific research and clinical trials to ensure efficacy and safety.
Pluri and Wilk Technologies’ collaboration represents an exciting step forward in the field of medical nutrition. The intelligent combination of advanced cell-expansion technology and the unique expertise in the development of cultured human breast and animal milk products lays the foundation for a potentially game-changing solution for the elderly population.
Comments